JAK inhibitors and myelofibrosis, Einstein and ruxolitinib

Haematologica. 2015 Apr;100(4):409-11. doi: 10.3324/haematol.2015.124099.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Nitriles
  • Primary Myelofibrosis / drug therapy*
  • Primary Myelofibrosis / mortality*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Pyrimidines

Substances

  • Nitriles
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib